<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04750070</url>
  </required_header>
  <id_info>
    <org_study_id>PR-20021</org_study_id>
    <nct_id>NCT04750070</nct_id>
  </id_info>
  <brief_title>Management of Shock in Children With SAM and Diarrhea</brief_title>
  <official_title>Randomized Controlled Trial of Dopamine, Adrenaline, and Blood Transfusion for Treatment of Fluid Refractory Shock in Children With Severe Acute Malnutrition and Cholera or Other Dehydrating Diarrheas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Centre for Diarrhoeal Disease Research, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Muhimbili University of Health and Allied Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>International Centre for Diarrhoeal Disease Research, Bangladesh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diarrhea is one of the leading causes of under-five childhood mortality and accounts for 8%&#xD;
      of 5.4 million global under-5 deaths. The coexistence of sepsis and hypovolemic shock in&#xD;
      children with severe acute malnutrition (SAM) having diarrhea is common. At Dhaka hospital of&#xD;
      icddr,b, the death rate is as high as 40% and 69% in children with severe sepsis and septic&#xD;
      shock respectively with co-morbidities such as severe malnutrition.&#xD;
&#xD;
      The conventional management of SAM children with features of severe sepsis recommended by WHO&#xD;
      includes administration of boluses of isotonic saline followed by blood transfusion in&#xD;
      unresponsive cases with septic shock; whereas the Surviving Sepsis Campaign (SSC) guideline&#xD;
      recommends vasoactive support. To date, no study has evaluated systematically the effects of&#xD;
      inotrope(s) and vasopressor or blood transfusion in children with dehydrating diarrhea (for&#xD;
      example, in cholera) and SAM having shock and unresponsive to WHO standard fluid therapy.&#xD;
&#xD;
      This randomized trial will generate evidence whether inotrope and vasopressor or blood&#xD;
      transfusion should be selected for severely malnourished children having hypotensive shock&#xD;
      and who failed to respond to WHO standard fluid bolus.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:&#xD;
&#xD;
        1. Burden: Burden: Diarrhea is one of the leading causes of under-five childhood mortality&#xD;
           and accounts for 8% of 5.4 million global under-5 deaths. Co-morbidity of severe acute&#xD;
           malnutrition (SAM) and shock in children with diarrhea is associated with increased&#xD;
           mortality. Nearly half of the patients admitted to the Intensive Care Unit (ICU) of&#xD;
           Dhaka Hospital of icddr,b present with sepsis. Data demonstrates that about 43% of&#xD;
           children progressed from severe sepsis to septic shock despite receiving recommended&#xD;
           treatment. The death rate was found to be as high as 40% and 69% in children with severe&#xD;
           sepsis and septic shock respectively with co-morbidities such as severe malnutrition.&#xD;
&#xD;
        2. Knowledge gap: The conventional management of SAM children with features of severe&#xD;
           sepsis recommended by WHO include administration of boluses of isotonic saline followed&#xD;
           by blood transfusion in unresponsive cases with septic shock. However, a recent African&#xD;
           study reported significantly higher mortality among children with features of severe&#xD;
           sepsis when they were treated with boluses. To date, no study has evaluated&#xD;
           systematically the effects of inotrope or vasopressor or blood transfusion in children&#xD;
           with dehydrating diarrhea (for example, in cholera) and SAM having shock and&#xD;
           unresponsive to WHO standard fluid therapy.&#xD;
&#xD;
        3. Relevance: If this randomized trial signifies survival benefit from a blood transfusion,&#xD;
           inotrope or vasopressor in the management of fluid refractory shock in children with&#xD;
           severe acute malnutrition and cholera or other dehydrating diarrheas, then this approach&#xD;
           would be a good candidate for implementation in the management of such children&#xD;
           especially in developing countries&#xD;
&#xD;
      Hypothesis: We hypothesize that the death rates will be significantly lower in children with&#xD;
      SAM, dehydrating diarrhea and fluid refractory shock who will be treated with dopamine or&#xD;
      adrenaline compared to blood transfusion, after treatment failure with WHO standard bolus&#xD;
      intravenous fluid therapy.&#xD;
&#xD;
      Objectives: To reduce mortality of the SAM children presenting with diarrhea and fluid&#xD;
      refractory shock who will receive WHO standard fluid therapy followed by dopamine or&#xD;
      adrenaline, compared to those receiving blood transfusion after WHO standard fluid therapy.&#xD;
&#xD;
      Methods: This will be a randomized, three-arm, controlled, non-masked clinical trial in&#xD;
      children 1- 59 months old with SAM and fluid refractory shock. It will compare the efficacy&#xD;
      of WHO-recommended fluid resuscitation followed by dopamine or adrenaline administration&#xD;
      versus WHO recommended fluid resuscitation followed by blood transfusion. After parental&#xD;
      written informed consent, children, in addition to usual supportive care, will be allocated&#xD;
      to the study interventions following randomization.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">February 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Systematic evaluation of the effects of inotrope(s) and vasopressor or blood transfusion in children with dehydrating diarrhea (for example, in cholera) and SAM having shock and unresponsive to WHO standard fluid therapy</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Case fatality rate</measure>
    <time_frame>28 days</time_frame>
    <description>Number of mortality among SAM children presenting with diarrhea and fluid refractory shock who would receive WHO standard fluid therapy followed by dopamine or adrenaline, compared to those receiving blood transfusion after WHO standard fluid therapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment failure rates</measure>
    <time_frame>Through study completion, an average of 7 days</time_frame>
    <description>Number of children where we failed to achieve the goal of resuscitation after starting any one of the interventions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for mechanical ventilation</measure>
    <time_frame>Through study completion, an average of 7 days</time_frame>
    <description>Number of children who would require mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure</measure>
    <time_frame>Through study completion, an average of 7 days</time_frame>
    <description>Number of children who developed heart failure. Heart failure will be assessed on the basis of - age-specific tachypnea, tachycardia, enlarged tender liver, pedal edema, basal crackles and/or gallop and response to furosemide (combination of findings).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>Through study completion, an average of 7 days</time_frame>
    <description>Time a child stays in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time-to-achieve recovery</measure>
    <time_frame>3-4 hours</time_frame>
    <description>Required times (minutes) for resuscitation of a child after randomization to a specific arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular function of the study participants</measure>
    <time_frame>Through study completion, an average of 7 days</time_frame>
    <description>Evaluation of left ventricular function (hyperdynamic or normal) by cardiac USG at enrollment, at time of heart failure (if any)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular function of the study participants</measure>
    <time_frame>Through study completion, an average of 7 days</time_frame>
    <description>Evaluation of right ventricular function (hyperdynamic or normal) by cardiac ultrasound at enrollment, at time of heart failure (if any)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inferior vena cava collapsibility of the study participants</measure>
    <time_frame>Through study completion, an average of 7 days</time_frame>
    <description>Evaluation of Inferior vena cava collapsibility by cardiac ultrasound at enrollment, at time of heart failure (if any)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Shock Hypovolemic</condition>
  <condition>Shock, Septic</condition>
  <condition>Blood Transfusion</condition>
  <condition>Adrenaline</condition>
  <condition>Dopamine</condition>
  <arm_group>
    <arm_group_label>Dopamine arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children in the dopamine arm (Treatment plan A) will receive dopamine, 8 microgram/kg/min (increasing the dose after 15 minutes to 12 microgram/kg/min to a maximum of 15 microgram/kg/min)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adrenaline arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children in the adrenaline arm (Treatment plan B) will receive adrenaline, 0.1 microgram/kg/min (increasing the dose after 15 minutes to 0.2 microgram/kg.min to a maximum of 0.3 microgram/kg.min)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blood transfusion arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children in the blood transfusion arm (Treatment plan C) will receive a transfusion of whole human blood in a dose of 10 mL/kg over 2-3 hours. While the blood transfusion is being arranged, IV fluid would be given @ of 3 ml per kg per hour</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dopamine</intervention_name>
    <description>Children will receive dopamine, 8 microgram/kg.min (increasing the dose after 15 minutes to 12 microgram/kg/min to a maximum of 15 microgram/kg/min)</description>
    <arm_group_label>Dopamine arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>adrenaline</intervention_name>
    <description>Children will receive adrenaline, 0.1 microgram/kg/min (increasing the dose after 15 minutes to 0.2 microgram/kg.min to a maximum of 0.3 microgram/kg.min)</description>
    <arm_group_label>Adrenaline arm</arm_group_label>
    <other_name>Epinephrine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Blood Transfusion</intervention_name>
    <description>Children will receive a transfusion of whole human blood in a dose of 10 mL/kg over 2-3 hours. While the blood transfusion is being arranged, IV fluid would be given @ of 3 ml per kg per hour</description>
    <arm_group_label>Blood transfusion arm</arm_group_label>
    <other_name>Blood</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Children of either sex with SAM and diarrhea&#xD;
&#xD;
          2. Age: 1-59 months&#xD;
&#xD;
          3. Fluid refractory shock&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Severe anemia (hemoglobin&lt; 5 gm/dl) who will require a blood transfusion&#xD;
&#xD;
          2. Sclerema&#xD;
&#xD;
          3. Congenital anomalies (TOF/ASD/VSD/Trisomy 21, etc.)&#xD;
&#xD;
          4. Developmental delay (H/O perinatal asphyxia/cerebral palsy)&#xD;
&#xD;
          5. Having a rare blood group&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>59 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tahmeed Ahmed, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Centre for Diarrhoeal Disease Research, Bangladesh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Monira Sarmin, MBBS, MCPS</last_name>
    <phone>+8801718596947</phone>
    <phone_ext>2186</phone_ext>
    <email>drmonira@icddrb.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Icddr,B</name>
      <address>
        <city>Dhaka</city>
        <zip>1000</zip>
        <country>Bangladesh</country>
      </address>
    </facility>
    <contact>
      <last_name>Monira Sarmin, MCPS</last_name>
      <email>drmonira@icddrb.org</email>
    </contact>
    <investigator>
      <last_name>Tahmeed Ahmed, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <reference>
    <citation>Organization WH. Pocket book of hospital care for children: guidelines for the management of common childhood illnesses: World Health Organization; 2013.</citation>
  </reference>
  <reference>
    <citation>AABB. Technical Manual. 19th ed. Fung MK, Eder AF, Spitalnik SL, Westhoff CM, editors. United States.</citation>
  </reference>
  <reference>
    <citation>Green REB, Klostermann DA. The Antiglobulin Test. In: Harmening D, editor. Modern Blood Banking &amp; Transfusion Practices. 6th ed. Philadelphia: F.A. Davis. p. 107-10.</citation>
  </reference>
  <results_reference>
    <citation>Chisti MJ, Pietroni MA, Smith JH, Bardhan PK, Salam MA. Predictors of death in under-five children with diarrhoea admitted to a critical care ward in an urban hospital in Bangladesh. Acta Paediatr. 2011 Dec;100(12):e275-9. doi: 10.1111/j.1651-2227.2011.02368.x. Epub 2011 Jun 21.</citation>
    <PMID>21627690</PMID>
  </results_reference>
  <results_reference>
    <citation>Sarmin M, Ahmed T, Bardhan PK, Chisti MJ. Specialist hospital study shows that septic shock and drowsiness predict mortality in children under five with diarrhoea. Acta Paediatr. 2014 Jul;103(7):e306-11. doi: 10.1111/apa.12640. Epub 2014 Apr 11.</citation>
    <PMID>24661049</PMID>
  </results_reference>
  <results_reference>
    <citation>Ahmed T, Ali M, Ullah MM, Choudhury IA, Haque ME, Salam MA, Rabbani GH, Suskind RM, Fuchs GJ. Mortality in severely malnourished children with diarrhoea and use of a standardised management protocol. Lancet. 1999 Jun 5;353(9168):1919-22.</citation>
    <PMID>10371570</PMID>
  </results_reference>
  <results_reference>
    <citation>Chisti MJ, Salam MA, Bardhan PK, Faruque AS, Shahid AS, Shahunja KM, Das SK, Hossain MI, Ahmed T. Severe Sepsis in Severely Malnourished Young Bangladeshi Children with Pneumonia: A Retrospective Case Control Study. PLoS One. 2015 Oct 6;10(10):e0139966. doi: 10.1371/journal.pone.0139966. eCollection 2015.</citation>
    <PMID>26440279</PMID>
  </results_reference>
  <results_reference>
    <citation>Sarker AR, Sultana M, Mahumud RA, Ali N, Huda TM, Salim Uzzaman M, Haider S, Rahman H, Islam Z, Khan JAM, Van Der Meer R, Morton A. Economic costs of hospitalized diarrheal disease in Bangladesh: a societal perspective. Glob Health Res Policy. 2018 Jan 5;3:1. doi: 10.1186/s41256-017-0056-5. eCollection 2018.</citation>
    <PMID>29318195</PMID>
  </results_reference>
  <results_reference>
    <citation>Guerrant RL, Schorling JB, McAuliffe JF, de Souza MA. Diarrhea as a cause and an effect of malnutrition: diarrhea prevents catch-up growth and malnutrition increases diarrhea frequency and duration. Am J Trop Med Hyg. 1992 Jul;47(1 Pt 2):28-35. Review.</citation>
    <PMID>1632474</PMID>
  </results_reference>
  <results_reference>
    <citation>Chisti MJ, Saha S, Roy CN, Salam MA. Predictors of bacteremia in infants with diarrhea and systemic inflammatory response syndrome attending an urban diarrheal treatment center in a developing country. Pediatr Crit Care Med. 2010 Jan;11(1):92-7. doi: 10.1097/PCC.0b013e3181b063e1.</citation>
    <PMID>19593244</PMID>
  </results_reference>
  <results_reference>
    <citation>Ranjit S, Aram G, Kissoon N, Ali MK, Natraj R, Shresti S, Jayakumar I, Gandhi D. Multimodal monitoring for hemodynamic categorization and management of pediatric septic shock: a pilot observational study*. Pediatr Crit Care Med. 2014 Jan;15(1):e17-26. doi: 10.1097/PCC.0b013e3182a5589c.</citation>
    <PMID>24196006</PMID>
  </results_reference>
  <results_reference>
    <citation>Davis AL, Carcillo JA, Aneja RK, Deymann AJ, Lin JC, Nguyen TC, Okhuysen-Cawley RS, Relvas MS, Rozenfeld RA, Skippen PW, Stojadinovic BJ, Williams EA, Yeh TS, Balamuth F, Brierley J, de Caen AR, Cheifetz IM, Choong K, Conway E Jr, Cornell T, Doctor A, Dugas MA, Feldman JD, Fitzgerald JC, Flori HR, Fortenberry JD, Graciano AL, Greenwald BM, Hall MW, Han YY, Hernan LJ, Irazuzta JE, Iselin E, van der Jagt EW, Jeffries HE, Kache S, Katyal C, Kissoon N, Kon AA, Kutko MC, MacLaren G, Maul T, Mehta R, Odetola F, Parbuoni K, Paul R, Peters MJ, Ranjit S, Reuter-Rice KE, Schnitzler EJ, Scott HF, Torres A Jr, Weingarten-Arams J, Weiss SL, Zimmerman JJ, Zuckerberg AL. American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. Crit Care Med. 2017 Jun;45(6):1061-1093. doi: 10.1097/CCM.0000000000002425. Erratum in: Crit Care Med. 2017 Sep;45(9):e993. Kissoon, Niranjan Tex [corrected to Kissoon, Niranjan]; Weingarten-Abrams, Jacki [corrected to Weingarten-Arams, Jacki].</citation>
    <PMID>28509730</PMID>
  </results_reference>
  <results_reference>
    <citation>Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, Levin M, Babiker AG, Gibb DM; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011 Jun 30;364(26):2483-95. doi: 10.1056/NEJMoa1101549. Epub 2011 May 26.</citation>
    <PMID>21615299</PMID>
  </results_reference>
  <results_reference>
    <citation>Seri I, Abbasi S, Wood DC, Gerdes JS. Regional hemodynamic effects of dopamine in the sick preterm neonate. J Pediatr. 1998 Dec;133(6):728-34.</citation>
    <PMID>9842034</PMID>
  </results_reference>
  <results_reference>
    <citation>Maitland K, George EC, Evans JA, Kiguli S, Olupot-Olupot P, Akech SO, Opoka RO, Engoru C, Nyeko R, Mtove G, Reyburn H, Brent B, Nteziyaremye J, Mpoya A, Prevatt N, Dambisya CM, Semakula D, Ddungu A, Okuuny V, Wokulira R, Timbwa M, Otii B, Levin M, Crawley J, Babiker AG, Gibb DM; FEAST trial group. Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Med. 2013 Mar 14;11:68. doi: 10.1186/1741-7015-11-68.</citation>
    <PMID>23496872</PMID>
  </results_reference>
  <results_reference>
    <citation>Phornphatkul C, Pongprot Y, Suskind R, George V, Fuchs G. Cardiac function in malnourished children. Clin Pediatr (Phila). 1994 Mar;33(3):147-54.</citation>
    <PMID>8194289</PMID>
  </results_reference>
  <results_reference>
    <citation>Ventura AM, Shieh HH, Bousso A, Góes PF, de Cássia F O Fernandes I, de Souza DC, Paulo RL, Chagas F, Gilio AE. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock. Crit Care Med. 2015 Nov;43(11):2292-302. doi: 10.1097/CCM.0000000000001260.</citation>
    <PMID>26323041</PMID>
  </results_reference>
  <results_reference>
    <citation>Ramaswamy KN, Singhi S, Jayashree M, Bansal A, Nallasamy K. Double-Blind Randomized Clinical Trial Comparing Dopamine and Epinephrine in Pediatric Fluid-Refractory Hypotensive Septic Shock. Pediatr Crit Care Med. 2016 Nov;17(11):e502-e512.</citation>
    <PMID>27673385</PMID>
  </results_reference>
  <results_reference>
    <citation>Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, Brierley J, Carcillo J, Carrol ED, Carroll CL, Cheifetz IM, Choong K, Cies JJ, Cruz AT, De Luca D, Deep A, Faust SN, De Oliveira CF, Hall MW, Ishimine P, Javouhey E, Joosten KFM, Joshi P, Karam O, Kneyber MCJ, Lemson J, MacLaren G, Mehta NM, Møller MH, Newth CJL, Nguyen TC, Nishisaki A, Nunnally ME, Parker MM, Paul RM, Randolph AG, Ranjit S, Romer LH, Scott HF, Tume LN, Verger JT, Williams EA, Wolf J, Wong HR, Zimmerman JJ, Kissoon N, Tissieres P. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med. 2020 Feb;21(2):e52-e106. doi: 10.1097/PCC.0000000000002198.</citation>
    <PMID>32032273</PMID>
  </results_reference>
  <results_reference>
    <citation>Sun JT. New Advances in Emergency Ultrasound Protocols for Shock. J Med Ultrasound. 2017 Oct-Dec;25(4):191-194. doi: 10.1016/j.jmu.2017.09.005. Epub 2017 Dec 6.</citation>
    <PMID>30065491</PMID>
  </results_reference>
  <results_reference>
    <citation>Sekiguchi H, Harada Y, Villarraga HR, Mankad SV, Gajic O. Focused cardiac ultrasound in the early resuscitation of severe sepsis and septic shock: a prospective pilot study. J Anesth. 2017 Aug;31(4):487-493. doi: 10.1007/s00540-017-2312-8. Epub 2017 Jan 31.</citation>
    <PMID>28144779</PMID>
  </results_reference>
  <results_reference>
    <citation>McQuilten ZK, Cooper DJ. Age of Red Blood Cells for Transfusion in Critically Ill Pediatric Patients. JAMA. 2019 Dec 10;322(22):2175-2176. doi: 10.1001/jama.2019.17476.</citation>
    <PMID>31821418</PMID>
  </results_reference>
  <results_reference>
    <citation>Tiwari AK, Aggarwal G, Dara RC, Arora D, Gupta GK, Raina V. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients. Asian J Transfus Sci. 2017 Jan-Jun;11(1):40-44. doi: 10.4103/0973-6247.200774.</citation>
    <PMID>28316439</PMID>
  </results_reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 1, 2021</study_first_submitted>
  <study_first_submitted_qc>February 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Severe acute malnutrition</keyword>
  <keyword>Children</keyword>
  <keyword>Shock</keyword>
  <keyword>Cholera</keyword>
  <keyword>Dehydrating diarrhea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Severe Acute Malnutrition</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Hypovolemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dopamine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

